Adolescents and young adults in the U.S. are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with metabolic and bariatric surgery (MBS) to manage obesity, according to a study by UT Southwestern Medical Center researchers published in JAMA Pediatrics.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 2 | 7 Natural Ways to Suppress Appetite Now, and What’s Ahead | 0 | 18.59 | 11-08-2026 |
| 3 | Weight Loss Medications May Affect Some Complications After Panniculectomy | 0 | 5.94 | 25-03-2026 |
| 4 | GLP-1 'secret shopper' study finds gaps in online prescribing | 0 | 5 | 07-07-2026 |
| 5 | Roux-en-Y gastric bypass, sleeve gastrectomy cost-effective for teens with severe obesity | 0 | 7 | 30-06-2026 |
| 6 | Ozempic and GLP-1 are the Gateway Drugs to a Truly Healthy Lifestyle and Population | 0 | 3.95 | 21-07-2026 |
| 7 | Weight-loss jab users more likely to report changes in taste and smell, study finds | 0 | 7 | 29-06-2026 |
| 8 | Can GLP-1s affect birth control, fertility? | 0 | 7.35 | 15-08-2026 |
| 9 | Women taking GLP-1 drugs more likely to land a job, study finds | 0 | 6.29 | 30-06-2026 |
| 10 | Statins and blood pressure drugs changing health risks of obesity, study suggests | 0 | 7 | 01-07-2026 |